222 results
8-K
EX-1.1
p1gt5n tt2n
26 Feb 24
Other Events
5:08pm
424B5
bs34b h5byqm6yru8snu
26 Feb 24
Prospectus supplement for primary offering
6:12am
424B5
5r2b2v
21 Feb 24
Prospectus supplement for primary offering
8:39am
8-K
EX-99.1
mis4oqxl owqrop
12 Feb 24
AbbVie Completes Acquisition of ImmunoGen
7:49am
8-K
EX-99.1
wk20f0c1
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
8:47am
11-K
wlnsap0a 8fhfvil
28 Jun 23
Annual report of employee stock purchases
5:00pm